EssilorLuxottica S.A. (ESLOY) Stock Price & Analysis
EssilorLuxottica S.A. (ESLOY) — price $80.65 (-0.62%), as of the Oct 2, 2026 trading session; market cap $74.1B. Expected results Feb 17, 2027.
Educational signal · not a buy or sell recommendation · How to read this
EssilorLuxottica S.A. · ESLOY · Healthcare · Medical - Instruments & Supplies
EssilorLuxottica S.A., established in Paris, France, in 1849, is a prominent global entity in the optical industry.
Price as of Oct 2, 2026
Key Statistics
No publishable V2 score is available for this stock yet.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $80.65 | |
| Change on the day | -0.62% | |
| 52-week range | $79.27 – $186.81 | |
| Market capitalisation | $74.1B | |
| Price / earnings (trailing) | 26.44 | |
| Shares traded on the day | 15.0K | |
| Beta (volatility vs the S&P 500) | 0.55 | |
| Dividends per share (last 12 months) | $2.32 | |
| Dividend yield (last 12 months) | 2.87% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · below the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
The provider's estimated date can change.
What to watch nextOther perspectives
Council score for EssilorLuxottica (ESLOY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
3 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 1, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 9, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the ESLOY film — every key number, told as a short cinematic story
~2 min · open the film
What is EssilorLuxottica (ESLOY), and what does it report?
Short answer · as of
EssilorLuxottica S.A., established in Paris, France, in 1849, is a prominent global entity in the optical industry. Healthcare / Medical Instruments & Supplies SEC filing business address: 147 RUE DE Paris, Charenton LE Pont, I0, 94220. It employs 203,791 people and is led by Francesco Milleri. In Q2 FY2026 it reported revenue of $16.90B and net income of $1.79B. The market values it at $74.1B.
What do the latest results show for EssilorLuxottica (ESLOY)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $16.90B. Against analyst estimates the company has EPS beat 3 of 8 reports.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $16.87B Jul 28, 2026
- Latest report · revenue estimate
- $17.05B Jul 28, 2026
- Latest report · revenue vs estimate
- Below estimate Jul 28, 2026
- Latest report · EPS vs estimate
- Below estimate Jul 28, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Jul 28, 2026 | $16.87B | $17.05B | $1.9200 | $2.2200 |
| Feb 11, 2026 | $17.19B | $16.31B | $1.7300 | $1.5700 |
| Jul 28, 2025 | $16.16B | $16.17B | $1.7300 | $2.2900 |
| Feb 12, 2025 | $13.79B | $13.54B | $1.5500 | $1.4500 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $16.90B | $1.79B | $1.92 (diluted) |
| Q4 FY2025 | $16.06B | $1.03B | $1.10 (diluted) |
| Q2 FY2025 | $15.69B | $1.55B | $1.68 (diluted) |
| Q4 FY2024 | $14.78B | $1.11B | $1.21 (diluted) |
What are the financial strengths and risks for EssilorLuxottica (ESLOY)?
Short answer
The distress and quality screens read Altman Z 3.14 · Piotroski F 7. Trailing ratios: ROE 6.0% · ROA 3.6% · current ratio 0.99 · earnings yield 3.0% · free-cash-flow yield 5.0%.
Data-derived red flags
- Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.
- Rich valuation — a P/E of 26.44 runs well above the Healthcare sector’s ~21.10x, leaving little room for a miss.
What should you watch next at EssilorLuxottica (ESLOY)?
Short answer · as of
The next earnings report is expected on Feb 17, 2027.
What the records here don't tell us
- Detailed statement figures are not shown because their conversion to USD has not been verified.
- No insider Form 4 transaction falls inside the window this page reads.
Checked against the records this page reads, on the dates shown above.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 0.0% Period end Jun 30, 2026
- Previous quarter · ownership
- 0.0% Prior to period end Jun 30, 2026
- Reporting holders
- 12 Period end Jun 30, 2026
- Previous quarter · holders
- 10 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Rhumbline Advisers | 19,877 |
| Gamma Investing LLC | 1,959 |
| Salomon & Ludwin, LLC | 466 |
| Westside Investment Management, INC. | 246 |
| Main Street Group, Ltd | 200 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about EssilorLuxottica (ESLOY)?
Common Questions About ESLOY (Healthcare)
Research dated 2026-09-12; the answers below are from that research, and the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
How do Varilux, Crizal and Transitions fit into EssilorLuxottica?
They are prescription-lens technologies within the lenses and optical instruments business, alongside corrective lenses, optician equipment and digital optical solutions. They show why EssilorLuxottica is more than a frame and sunglasses company.
Why does EssilorLuxottica sell laboratory machinery alongside Foster Grant readers?
The company participates across the vision-care chain, supplying consumers with readers while also equipping laboratories and optical manufacturers with surfacing and coating machinery. That combination links consumer brands with business-to-business production infrastructure.
What is the ESLOY stock price today?
The last price recorded on this page for EssilorLuxottica S.A. (ESLOY) is $80.65, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Does ESLOY pay a dividend?
Yes. EssilorLuxottica S.A. (ESLOY) shows a trailing 12-month dividend yield of 2.87%, as of Oct 2, 2026, in the data on this page. Payout ratio and cash-flow coverage decide whether it can last, and past dividends do not guarantee future payments.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (50 figures)
The 50 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 1 fact from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
id.hq | SEC filing business address | 147 RUE DE Paris, Charenton LE Pont, I0, 94220 | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "1-5 rue Paul CEzanne, Paris, IF, 75008, FR". |
FMP — 40 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $80.65 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T20:54:54.614Z. | |
px.change | Change on the day | -0.62% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $74.1B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:00.000Z. Captured from FMP at 2026-10-04T20:54:53.038Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
earn.next | Next earnings date | Feb 17, 2027 | FMP | Financial Modeling Prep (FMP) earnings calendar — The date is our provider's estimate until the company confirms it. | |
id.business_summary | Business description (FMP excerpt) | EssilorLuxottica S.A., established in Paris, France, in 1849, is a prominent global entity in the optical industry. | FMP | Financial Modeling Prep (FMP) company profile — Deterministic excerpt derived from id.description; source and date describe the input fact, not a new provider observation | |
px.change_abs | Change on the day, in dollars | −$0.50 | FMP | Financial Modeling Prep (FMP) · quote | |
px.pe | Price / earnings (trailing) | 26.44 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 15.0K | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 0.55 | FMP | Financial Modeling Prep (FMP) company profile | |
id.sector | Sector / industry (provider taxonomy) | Healthcare / Medical Instruments & Supplies | FMP | Financial Modeling Prep (FMP) company profile — The company's SEC filings classify it under SIC 8880 — American Depositary Receipts. | |
id.employees | Employees | 203,791 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Francesco Milleri | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
fin.q_revenue | Revenue, Q2 FY2026 | $16.90B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q2 FY2026 | $1.79B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
earn.history.depth.2026-07-28.revenue_actual | Revenue · reported — report date 2026-07-28 | $16.87B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-28.revenue_estimated | Revenue · estimate — report date 2026-07-28 | $17.05B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-28.eps_actual | EPS · reported — report date 2026-07-28 | $1.9200 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-28.eps_estimated | EPS · estimate — report date 2026-07-28 | $2.2200 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-11.revenue_actual | Revenue · reported — report date 2026-02-11 | $17.19B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-11.revenue_estimated | Revenue · estimate — report date 2026-02-11 | $16.31B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-11.eps_actual | EPS · reported — report date 2026-02-11 | $1.7300 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-11.eps_estimated | EPS · estimate — report date 2026-02-11 | $1.5700 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-28.revenue_actual | Revenue · reported — report date 2025-07-28 | $16.16B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-28.revenue_estimated | Revenue · estimate — report date 2025-07-28 | $16.17B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-28.eps_actual | EPS · reported — report date 2025-07-28 | $1.7300 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-07-28.eps_estimated | EPS · estimate — report date 2025-07-28 | $2.2900 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-02-12.revenue_actual | Revenue · reported — report date 2025-02-12 | $13.79B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-02-12.revenue_estimated | Revenue · estimate — report date 2025-02-12 | $13.54B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-02-12.eps_actual | EPS · reported — report date 2025-02-12 | $1.5500 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-02-12.eps_estimated | EPS · estimate — report date 2025-02-12 | $1.4500 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
own.institutions.depth.ownership_pct | Institutional ownership | 0.0% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.ownership_pct_previous_quarter | Previous quarter · ownership | 0.0% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.institutions.depth.holders | Reporting holders | 12 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 10 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | Rhumbline Advisers — shares in provider snapshot | 19,877 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_1.shares | Gamma Investing LLC — shares in provider snapshot | 1,959 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_2.shares | Salomon & Ludwin, LLC — shares in provider snapshot | 466 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_3.shares | Westside Investment Management, INC. — shares in provider snapshot | 246 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_4.shares | Main Street Group, Ltd — shares in provider snapshot | 200 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 4 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.range52 | 52-week range | $79.27 – $186.81 | UNRECORDED | Stored company-profile observation — Captured 2026-10-03 | |
earn.history | Reported versus estimated, recent quarters | EPS beat 3 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-01 · Expired observation | |
fin.scores | Distress and quality screens | Altman Z 3.14 · Piotroski F 7 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-05 | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 6.0% · ROA 3.6% · current ratio 0.99 · earnings yield 3.0% · free-cash-flow yield 5.0% | — | UNRECORDED | Stored key metrics — Date unknown |
COMPUTED — 4 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
div.ttm_per_share | Dividends per share, last 12 months (split-adjusted) | $2.32 | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history — Sum of 1 split-adjusted declared dividend with an ex-date in the 365 days to 2026-10-05, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate. | |
div.ttm_yield | Dividend yield, last 12 months | 2.87% | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history and quote — Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate. | |
earn.history.depth.2026-07-28.revenue_actual.comparison | Latest report · revenue vs estimate | Below estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($16.87B) with the recorded estimate ($17.05B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-07-28.eps_actual.comparison | Latest report · EPS vs estimate | Below estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($1.9200) with the recorded estimate ($2.2200) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 1 fact from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
gap.statement_currency | Statement currency limitation | Detailed statement figures are not shown because their conversion to USD has not been verified. | OURS | Stock Expert AI currency-basis check |
Fact-family notes
- Earnings-history note. Source series as of 2026-07-28. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-07-28.revenue_actual,earn.history.depth.2026-07-28.revenue_estimated,earn.history.depth.2026-07-28.revenue_actual.comparison,earn.history.depth.2026-07-28.eps_actual.comparison,earn.history.depth.2026-07-28.eps_actual,earn.history.depth.2026-07-28.eps_estimated,earn.history.depth.2026-02-11.revenue_actual,earn.history.depth.2026-02-11.revenue_estimated,earn.history.depth.2026-02-11.eps_actual,earn.history.depth.2026-02-11.eps_estimated,earn.history.depth.2025-07-28.revenue_actual,earn.history.depth.2025-07-28.revenue_estimated,earn.history.depth.2025-07-28.eps_actual,earn.history.depth.2025-07-28.eps_estimated,earn.history.depth.2025-02-12.revenue_actual,earn.history.depth.2025-02-12.revenue_estimated,earn.history.depth.2025-02-12.eps_actual,earn.history.depth.2025-02-12.eps_estimated.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-12
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Business description | EssilorLuxottica S.A., established in Paris, France, in 1849, is a prominent global entity in the optical industry. The company specializes in the creation, production, and worldwide distribution of a diverse range of vision products, including ophthalmic lenses, eyewear frames, and sunglasses, catering to markets across North America, Europe, Latin America, Asia, Oceania, and Africa. Its extensive operations are divided into five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale division is responsible for manufacturing and supplying premium and athletic eyewear to other businesses. Conversely, the Retail segment directly offers luxury and sports eyewear to consumers through its various sales channels. The Lenses and Optical Instruments segment provides a broad spectrum of lenses, such as Varilux progressive lenses, Crizal anti-reflective and anti-smudge coatings, Transitions photochromic lenses (including the Gen 8 series), Eyezen lenses optimized for digital screen use, and Xperio polarized sun lenses, alongside corrective options from Nikon and Kodak. This segment also furnishes optical instruments, including lens edging and mounting equipment for opticians and laboratories, and optometry tools for a variety of professionals and institutions, while also developing online optical sales solutions. The Equipment segment focuses on delivering advanced digital surfacing and lens coating machinery to prescription laboratories, integrated optical chains, and lens manufacturers. Lastly, the Sunglasses and Readers segment encompasses a wide array of non-prescription sunglasses and reading glasses, available under numerous well-known proprietary brands like Foster Grant, Magnivision, and SolarShield, licensed brands such as Reebok, Steve Madden, and Disney, and regional labels including Bolon and Mujosh. To support its expansive business, EssilorLuxottica maintains a substantial network of 490 prescription laboratories and edging-mounting facilities globally. The company formally adopted the name EssilorLuxottica Société anonyme in October 2018, having previously been known as Essilor International Société Anonyme. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
| Sector / industry (provider taxonomy) | Healthcare / Medical - Instruments & Supplies The company's SEC filings classify it under SIC 8880 — American Depositary Receipts. | 2026-09-12 | FMP | Financial Modeling Prep (FMP) company profile |
Data provided for informational purposes only.